SNORD90 induces glutamatergic signaling following treatment with monoaminergic antidepressants

Pharmacotherapies for the treatment of major depressive disorder were serendipitously discovered almost seven decades ago. From this discovery, scientists pinpointed the monoaminergic system as the primary target associated with symptom alleviation. As a result, most antidepressants have been engine...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Rixing, Kos, Aron, Lopez, Juan Pablo, Dine, Julien, Fiori, Laura M, Yang, Jennie, Ben-Efraim, Yair, Aouabed, Zahia, Ibrahim, Pascal, Mitsuhashi, Haruka, Wong, Tak Pan, Ibrahim, El Cherif, Belzung, Catherine, Blier, Pierre, Farzan, Faranak, Frey, Benicio N, Lam, Raymond W, Milev, Roumen, Muller, Daniel J, Parikh, Sagar V, Soares, Claudio, Uher, Rudolf, Nagy, Corina, Mechawar, Naguib, Foster, Jane A, Kennedy, Sidney H, Chen, Alon, Turecki, Gustavo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2023
Materias:
Chromosomes and Gene Expression
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335830/
https://www.ncbi.nlm.nih.gov/pubmed/37432876
http://dx.doi.org/10.7554/eLife.85316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335830/
https://www.ncbi.nlm.nih.gov/pubmed/37432876
http://dx.doi.org/10.7554/eLife.85316

Ejemplares similares